Lymphoma,MZL (Marginal Zone Lymphoma) Rituximab Plus Ibrutinib Show Efficacy and Safety in Untreated MZL Aug 18, 2023
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Axi-cel as a Second-line Therapy for LBCL Pts-Ineligible for HDCT/HSCT Aug 17, 2023
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Consolidative HCT-ASCT Improves PFS In Newly-Diagnosed PCNSL Aug 16, 2023
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma ctDNA as a Noninvasive Biomarker in High-Risk LBCL Aug 16, 2023
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Axi-Cel Versus SOC in Patients With Early R/R LBCL Aug 11, 2023
Lymphoma,Other Cancers Liso-cel In R/R MCL: TRANSCEND NHL 001 Study Primary Analysis Results Aug 03, 2023
Lymphoma,Other Cancers BrECADD Shows Similar Efficacy to eBEACOPP in AS-cHL: HD21 Trial Results Jul 31, 2023
